|
Muthiah A, Aggarwal V, Muthiah C, Wei C, Ollila T, Quesenberry MI, Dizon DS.
"Analysis of Hematology and Oncology Fellowship Website Content and Diversity Representation." JCO Oncology Practice, 2022, pp. OP2100623.
|
|
Ollila T, Butera J, Egan P, Reagan J, Thomas A, Yakirevich I, MacKinnon K, Margolis J, McMahon J, Rosati V, Olszewski AJ.
"Vincristine Sulfate Liposome Injection with Bendamustine and Rituximab as First-Line Therapy for B-Cell Lymphomas: A Phase I Study." The oncologist, vol. 27, no. 7, 2022, pp. 532-e542.
|
|
Ollila TA, Lu S, Masel R, Zayac A, Paiva K, Rogers RD, Olszewski AJ.
"Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease." JAMA Oncology, vol. 7, no. 11, 2021, pp. 1714-1716.
|
|
Ollila TA, Olszewski AJ.
"Chemotherapy-Free Management of Follicular and Marginal Zone Lymphoma." Cancer management and research, vol. 13, 2021, pp. 3935-3952.
|
|
Olszewski AJ, Chorzalska AD, Petersen M, Ollila TA, Zayac A, Kurt H, Treaba DO, Reagan JL, Hsu A, Egan PC, Butera J, Niroula R, Vatkevich J, Robison J, Sahin I, Jacob AP, Mullins CD, Dubielecka PM.
"Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma." Blood Advances, vol. 5, no. 24, 2021, pp. 5525-5535.
|
|
Ollila TA, Kurt H, Waroich J, Vatkevich J, Sturtevant A, Patel NR, Dubielecka PM, Treaba DO, Olszewski AJ.
"Genomic subtypes may predict the risk of central nervous system recurrence in diffuse large B-cell lymphoma." Blood, vol. 137, no. 8, 2021, pp. 1120-1124.
|
|
Orellana-Noia VM, Reed DR, McCook AA, Sen JM, Barlow CM, Malecek MK, Watkins M, Kahl BS, Spinner MA, Advani R, Voorhees TJ, Snow A, Grover NS, Ayers A, Romancik J, Liu Y, Huntington SF, Chavez JC, Saeed H, Lazaryan A, Raghunathan V, Spurgeon SE, Ollila TA, Del Prete C, Olszewski A, Ayers EC, Landsburg DJ, Echalier B, Lee J, Kamdar M, Caimi PF, Fu T, Liu J, David KA, Alharthy H, Law J, Karmali R, Shah H, Stephens DM, Major A, Rojek AE, Smith SM, Yellala A, Kallam A, Nakhoda S, Khan N, Sohail MA, Hill BT, Barrett-Campbell O, Lansigan F, Switchenko J, Cohen J, Portell CA.
"Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions." Blood, vol. 139, no. 3, 2021, pp. 413-423.
|
|
Zayac AS, Hilliard RW, Olszewski AJ, Pelcovits A, Reagan JL, Hsu A, Riley D, Austin M, Ollila TA.
"Enforcing the "4T": An In-Line Calculator for HIT Antibody Ordering in the Electronic Medical Record." Rhode Island medical journal (2013), vol. 103, no. 8, 2020, pp. 78-83.
|
|
Di M, Ollila TA, Olszewski AJ.
"Exposure to ibritumomab tiuxetan and incidence of treatment-related myeloid neoplasms among older patients with B-cell lymphoma: a population-based study." Leukemia, vol. 34, no. 10, 2020, pp. 2794-2797.
|
|
Bakow BR, Elco CP, LeGolvan M, Dizon D, Ollila TA.
"Molecular Profiles of Brain and Pulmonary Metastatic Disease in Cancer of Unknown Primary." The oncologist, vol. 25, no. 7, 2020, pp. 555-559.
|
|
Ollila TA.
"Navigating Roadblocks as an Early Career Attending … Literally." The oncologist, vol. 25, no. 11, 2020, pp. 995-996.
|
|
Marks EI, Ollila TA.
"Acanthocytosis causing chronic hemolysis in a patient with advanced cirrhosis." Blood, vol. 133, no. 13, 2019, pp. 1518.
|
|
Ollila TA, Reagan JL, Olszewski AJ.
"Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data Base." Leukemia & Lymphoma, vol. 60, no. 14, 2019, pp. 3426-3433.
|
|
Ollila TA, Sahin I, Olszewski AJ.
"Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma." OncoTargets and therapy, vol. 12, 2019, pp. 1085-1094.
|
|
Ollila TA, Olszewski AJ.
"Radiation therapy in primary testicular lymphoma: does practice match the standard of care?." Leukemia & Lymphoma, vol. 60, no. 2, 2019, pp. 523-526.
|
|
Ollila TA, Olszewski AJ.
"Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence." Current treatment options in oncology, vol. 19, no. 8, 2018, pp. 38.
|
|
Ollila TA, Olszewski AJ, Butera JN, Quesenberry MI, Quesenberry PJ, Reagan JL.
"Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual Disease." Clinical lymphoma, myeloma & leukemia, vol. 18, no. 3, 2018, pp. 204-209.
|
|
Olszewski AJ, Ollila T, Reagan JL.
"Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas." British Journal of Haematology, vol. 181, no. 4, 2018, pp. 495-504.
|
|
Ollila T, Naeem S, Poppas A, McKendall G, Ehsan A.
"Embolization of Inferior Vena Cava Filter Tyne and Right Ventricular Perforation: A Cardiac Missile." The Annals of Thoracic Surgery, vol. 102, no. 6, 2016, pp. e515-e516.
|
